Skip to main content

Table 1 Demographic and clinical manifestations of SLE patients

From: Co-positivity of anti-dsDNA, anti-nucleosome, and anti-smith autoantibodies as serological biomarkers for disease activity in systemic lupus erythematosus

Items

No. (%)/mean (range)

Female:male ratio

75 (93.7%)/5 (6.3%)

Age (years)

34.3 (18–50)

Disease duration (years)

4.931 (1–10)

Clinical manifestations

 Constitutional

25 (31.25%)

 Mucocutaneous

74 (92.5%)

 Musculoskeletal

74 (92.5%)

 Lupus nephritis

37 (46.25%)

 Cardiovascular

4(5%)

 Pulmonary

5 (6.3%)

 Neuropsychiatric

3 (3.75%)

 Hematological

47 (58.75%)

 SLEDAI (mean ± SD)

17.11 ± 11.55